A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Linezolid-D8 | CAS 1032182-14-1 - Request Quote

Picture of Linezolid-D8

Linezolid-D8

SZ CAT No:SZ-L025D02
CAS No
1032182-14-1
Mol.F.
C16H12D8FN3O4
Mol.Wt.
345.4
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Linezolid-D8 is chemically (S)-N-((3-(3-Fluoro-4-(morpholino-d8)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide. Linezolid-D8 is supplied with detailed characterization data compliant with regulatory guideline. Linezolid-D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linezolid.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1032182-14-1

Purchase 1032182-14-1

Order 1032182-14-1

Enquire 1032182-14-1

price of 1032182-14-1

1032182-14-1 Supplier

1032182-14-1 Manufacturer

1032182-14-1 Exporter

buy high quality Linezolid-D8

Purchase Linezolid-D8

Linezolid-D8 suppliers

Linezolid-D8 manufacturers

Linezolid-D8 price

Order Linezolid-D8

Enquire Linezolid-D8

Linezolid-D8 cost

Linezolid-D8 Supplier

Linezolid-D8 Distributor

Linezolid-D8 for Method Validation

Linezolid Reference Standard

Linezolid-D8 for ANDA Filing

Linezolid-D8 for Forced Degradation Studies

Linezolid-D8 Identification Standards

Linezolid-D8 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,